PATENT CLAIM ANALYSIS

Application Number: 15966238
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "024000"]

Abstract:
Pharmaceutical dosage forms useful for improving the cardiovascular and/or metabolic health of patients, particularly those suffering from type 2 diabetes, are disclosed, as well as methods of their manufacture.

Claim (Index 15):
The method of  claim 14 , wherein the second medication is a biguanide.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 91.0
- Lexical Diversity: 1.13793
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13925981', '14593071', '13845466', '11862690', '14122836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8423641944206726
- 35 USC 102 Novelty (BERT): 0.5490778955758666
- Combined Prediction Score: 0.813035564536192
- Mean Citation Score: 425.776426
- Max Citation Score: 430.79868
- Similarity Product: 294.42395848304267

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test